The ATP5G1 antibody is a research tool targeting the ATP synthase membrane subunit 5G1 (ATP5G1), a critical component of mitochondrial ATP synthase (Complex V). ATP5G1. also known as ATP synthase F0 subunit C1. forms part of the F0 proton channel in the mitochondrial inner membrane. This subunit plays a key role in oxidative phosphorylation by facilitating proton translocation during ATP synthesis, coupling proton motive force to ATP production.
Antibodies against ATP5G1 are widely used to study mitochondrial function, energy metabolism, and diseases linked to mitochondrial dysfunction, such as neurodegenerative disorders, cancer, and metabolic syndromes. They enable detection of ATP5G1 expression levels via techniques like Western blotting, immunofluorescence, and immunohistochemistry, helping researchers assess mitochondrial density or metabolic shifts in cells/tissues.
Recent studies highlight ATP5G1's involvement in tumor progression, as altered expression correlates with cancer cell survival, metastasis, and chemoresistance. Additionally, ATP5G1 variants are implicated in rare mitochondrial encephalopathies. These antibodies also aid in exploring autophagy and apoptosis pathways, where mitochondrial ATP synthase dynamics influence cell fate. Validated for specificity across species (human, mouse, rat), ATP5G1 antibodies serve as essential probes for decoding cellular bioenergetics and disease mechanisms.